All Pharma News
UMC Utrecht And VectorY Collaborate In ALS Biomarker Study

UMC Utrecht And VectorY Collaborate In ALS Biomarker Study
BUSINESSWIRE
17 Jun 2024
Share Share
VectorY Appoints Khurem Farooq to Board of Directors

VectorY Appoints Khurem Farooq to Board of Directors
BUSINESSWIRE
18 Jan 2024
Share Share
VectorY Raises €129 Million ($138 Million) Series A Financing

VectorY Raises €129 Million ($138 Million) Series A Financing
BUSINESSWIRE
13 Nov 2023
Share Share
VectorY raises $138M to push forward ALS program

VectorY raises $138M to push forward ALS program
FIERCE BIOTECH
13 Nov 2023
Share Share
VectorY and Annogen Announce Collaboration for CNS-cell Specific Promoters

VectorY and Annogen Announce Collaboration for CNS-cell Specific Promoters
BUSINESSWIRE
19 Jan 2023
Share Share
VectorY Appoints Sander van Deventer as CEO and Makes Key Appointments

VectorY Appoints Sander van Deventer as CEO and Makes Key Appointments
BUSINESSWIRE
08 Nov 2022
Share Share
VectorY Appoints Sander van Deventer as CEO

VectorY Appoints Sander van Deventer as CEO
BUSINESSWIRE
08 Nov 2022
Share Share
VectorY Announces Participation in Scientific Conferences in October 2022

VectorY Announces Participation in Scientific Conferences in October 2022
BUSINESSWIRE
06 Oct 2022
Share Share
VectorY to Present on Huntington’s PC Data at Hereditary Disease Foundation

VectorY to Present on Huntington’s PC Data at Hereditary Disease Foundation
BUSINESSWIRE
23 Aug 2022
Share Share
VectorY presents pre-clinical data at the European Network for the Cure of ALS

VectorY presents pre-clinical data at the European Network for the Cure of ALS
BUSINESSWIRE
02 Jun 2022
Share Share